CPV (Canine Parvovirus) IgG ELISA Kit (Dog)


Canine parvovirus IgG ELISA kit is designed to determine quantitative amounts of IgG antibodies directed against canine parvovirus (CPV IgG)(dog) in samples of plasma or serum. This assay has a quantitative and qualitative standard range.


Canine parvovirus (CPV) is a contagious viral infection that affects dogs, which can exist in two different forms. The intestinal form is the most common, characterised by weight loss, lack of appetite, anorexia and vomiting. The cardiac form is the less common, this can attack the heart muscles of very young puppies often resulting in death. Majority of cases for this infection have been identified in puppies between 6 weeks to 6 months old. CPV infections for majority of the time are caused by a genetic alteration of the original canine parvovirus (i.e. canine parvovirus type 2b), these parvovirus can be spread through either direct contact with infected dog or indirectly via the fecal-oral route. The infection incidence rates have been radically reduced through early vaccination of young puppies. CPV can be diagnosed with a physical examination, abdominal radiographs/ultrasounds, biochemical tests and urine analysis. Also, for diagnosis of canine parvovirus infection or vaccination control another common used procedure includes analysing antibody titre. The following procedure is composed of the virus that is able to attach to the solid phase by using specific monoclonal antibodies.  IgG antibody titers that are above a dilution of 1:810 are frequently regarded as being protected.


All reagents supplied need to be stored at 2 °C – 8 °C, unopened reagents will retain reactivity until expiration date. Do not use reagents beyond this date.

  • Coated Microtiter Strips.
  • Strip Holder.
  • Inactivated Canine Parvo Virus Antigen.
  • ELISA Buffer.
  • HRPO Conjugate.
  • Positive Control (Freeze Dried).
  • Negative Control (Freeze Dried).
  • Wash Solution (200x Concentrated).
  • Substrate Buffer A.
  • Substrate Buffer B.
  • Stop Solution.
  • Cover Seal.


The standard range of IgG antibodies to CPV using current canine parvovirus (CPV) IgG ELISA kit is qualitative and quantitative. Please contact us for the protocol insert for more details.


– Canine Parvovirus (CPV) IgG: ELISA
– Negative control (at the 1:30 dilution) should give an OD < 0.400.
– End point titer of the positive control should be between 1:150 and 1:450.
– The test is valid if the first two dilutions of the positive control are above 0.500 OD (450 nm).
– In Summary:
(i). 30: = No antibodies found.
(ii). 90-270: = Antibodies found.
(iii). ≥ 810: = High titer of antibodies found.


  1. Evaluation of Immunity and Seropositivity of IgG Antibodies to Canine Parvoviruses in Vaccinated and Unvaccinated Dogs in Abeokuta, Nigeria. J Immunoassay Immunochem. (2016) 37 (1): 16-28. Babalola E.T., et al.
  2. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine. (1998) 16 (6): 601-7. Jiang W., et al.
  3. Systemic and local intestinal antibody response in dogs given both infective and inactivated canine parvovirus. Am J Vet Res. (1983) 44 (11): 1989-95. Nara P.L., et al.
  4. Magnetic protein microbead-aided indirect fluoroimmunoassay for the determination of canine virus specific antibodies. Biosens Bioelectron. (2011) 26 (7): 3353-60. Wang X., et al.


  • Full Name: CPV (Canine Parvovirus) IgG ELISA Kit (Dog)
  • Reactivity: Canine
  • Sample Type: Serum, Plasma
  • Sensitivity: Qualitative, Quantitative



Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford